Design Therapeutics stock up as RBC upgrades (DSGN:NASDAQ)

Design Therapeutics (DSGN) added ~15% on Thursday after RBC Capital Markets upgraded the stock to Outperform from Sector Perform, citing a catalyst-rich period for the small molecule drug developer in the near-term. The upgrade comes after the Carlsbad, California-based Design ( ...